Real-time Estimate
Cboe BZX
02:58:39 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
68.66
USD
|
+1.35%
|
|
+1.05%
|
+7.61%
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,651
|
8,528
|
8,167
|
2,369
|
2,902
|
3,841
|
-
|
-
|
Enterprise Value (EV)
1 |
7,283
|
10,033
|
10,217
|
5,252
|
5,480
|
6,085
|
5,937
|
5,739
|
P/E ratio
|
12.4
x
|
22.5
x
|
16.3
x
|
-5.43
x
|
-7.61
x
|
22.8
x
|
17.2
x
|
13.8
x
|
Yield
|
2.19%
|
4.81%
|
1.72%
|
6.18%
|
5.11%
|
3.97%
|
4.1%
|
4.23%
|
Capitalization / Revenue
|
1.79
x
|
2.06
x
|
1.66
x
|
0.6
x
|
0.82
x
|
1.06
x
|
1.04
x
|
1.01
x
|
EV / Revenue
|
2.31
x
|
2.43
x
|
2.07
x
|
1.34
x
|
1.54
x
|
1.68
x
|
1.6
x
|
1.51
x
|
EV / EBITDA
|
13
x
|
13.1
x
|
11.3
x
|
9.41
x
|
12.3
x
|
11
x
|
9.7
x
|
8.32
x
|
EV / FCF
|
39.5
x
|
20.3
x
|
62.1
x
|
-21.7
x
|
12.5
x
|
11.1
x
|
20.8
x
|
16.9
x
|
FCF Yield
|
2.53%
|
4.94%
|
1.61%
|
-4.62%
|
8%
|
9.05%
|
4.81%
|
5.91%
|
Price to Book
|
1.87
x
|
12.2
x
|
8.03
x
|
16.1
x
|
-10.8
x
|
-20.8
x
|
367
x
|
18.7
x
|
Nbr of stocks (in thousands)
|
55,497
|
55,769
|
55,801
|
55,406
|
56,156
|
56,692
|
-
|
-
|
Reference price
2 |
101.8
|
152.9
|
146.4
|
42.75
|
51.68
|
67.75
|
67.75
|
67.75
|
Announcement Date
|
11/6/19
|
11/4/20
|
11/3/21
|
11/2/22
|
11/1/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,156
|
4,132
|
4,925
|
3,924
|
3,551
|
3,612
|
3,704
|
3,807
|
EBITDA
1 |
558.2
|
766.6
|
902.6
|
557.9
|
446.9
|
549.7
|
612.2
|
689.7
|
EBIT
1 |
422.9
|
602
|
752.1
|
418.2
|
291.7
|
411.9
|
481.4
|
563.8
|
Operating Margin
|
13.4%
|
14.57%
|
15.27%
|
10.66%
|
8.21%
|
11.41%
|
13%
|
14.81%
|
Earnings before Tax (EBT)
1 |
581.6
|
510.6
|
677.1
|
-558.1
|
-453.3
|
254.4
|
322.2
|
401.6
|
Net income
1 |
460.7
|
387.4
|
512.5
|
-437.5
|
-380.1
|
178.5
|
229.4
|
286.1
|
Net margin
|
14.6%
|
9.38%
|
10.41%
|
-11.15%
|
-10.7%
|
4.94%
|
6.19%
|
7.52%
|
EPS
2 |
8.180
|
6.810
|
8.960
|
-7.880
|
-6.790
|
2.967
|
3.940
|
4.907
|
Free Cash Flow
1 |
184.4
|
495.3
|
164.6
|
-242.5
|
438.2
|
550.6
|
285.4
|
339
|
FCF margin
|
5.84%
|
11.99%
|
3.34%
|
-6.18%
|
12.34%
|
15.25%
|
7.7%
|
8.91%
|
FCF Conversion (EBITDA)
|
33.03%
|
64.61%
|
18.24%
|
-
|
98.05%
|
100.17%
|
46.61%
|
49.15%
|
FCF Conversion (Net income)
|
40.03%
|
127.85%
|
32.12%
|
-
|
-
|
308.46%
|
124.41%
|
118.49%
|
Dividend per Share
2 |
2.230
|
7.360
|
2.520
|
2.640
|
2.640
|
2.691
|
2.778
|
2.866
|
Announcement Date
|
11/6/19
|
11/4/20
|
11/3/21
|
11/2/22
|
11/1/23
|
-
|
-
|
-
|
Fiscal Period: September |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
737.8
|
566
|
1,678
|
1,186
|
493.6
|
526.6
|
1,532
|
1,119
|
374.5
|
410.4
|
1,489
|
1,238
|
469.4
|
418.8
|
1,506
|
EBITDA
1 |
-9
|
-8.5
|
429.6
|
209.6
|
-71.3
|
21.2
|
404.8
|
127
|
-106.1
|
-25.8
|
365.8
|
239.6
|
-35.12
|
-20.8
|
399.8
|
EBIT
1 |
-34
|
-33.7
|
393.3
|
161.7
|
-103
|
-41.8
|
346.7
|
111.8
|
-143.7
|
-47.3
|
327.5
|
201.9
|
-65.2
|
-52.27
|
366.3
|
Operating Margin
|
-4.61%
|
-5.95%
|
23.43%
|
13.63%
|
-20.87%
|
-7.94%
|
22.64%
|
9.99%
|
-38.37%
|
-11.53%
|
21.99%
|
16.31%
|
-13.89%
|
-12.48%
|
24.32%
|
Earnings before Tax (EBT)
1 |
-63.1
|
-64.7
|
-
|
-
|
-271.6
|
-
|
-
|
52
|
-560.7
|
-114.2
|
273
|
177.8
|
-117
|
-106.2
|
319.6
|
Net income
1 |
-47.8
|
-50
|
276.5
|
-443.9
|
-220.1
|
-64.7
|
109.4
|
43.7
|
-468.4
|
-80.5
|
192.4
|
125.4
|
-82.5
|
-74.9
|
225.4
|
Net margin
|
-6.48%
|
-8.83%
|
16.47%
|
-37.43%
|
-44.59%
|
-12.29%
|
7.14%
|
3.91%
|
-125.07%
|
-19.62%
|
12.92%
|
10.13%
|
-17.57%
|
-17.88%
|
14.96%
|
EPS
2 |
-0.8600
|
-0.9000
|
4.940
|
-8.010
|
-3.970
|
-1.170
|
1.940
|
0.7700
|
-8.330
|
-1.420
|
3.340
|
2.160
|
-1.420
|
-1.295
|
3.860
|
Dividend per Share
2 |
0.6600
|
0.6600
|
0.6600
|
0.6600
|
0.6600
|
0.6600
|
-
|
0.6600
|
0.6600
|
-
|
0.7042
|
0.6892
|
0.7042
|
0.7228
|
0.7228
|
Announcement Date
|
11/3/21
|
2/1/22
|
5/3/22
|
8/3/22
|
11/2/22
|
2/1/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,633
|
1,505
|
2,050
|
2,884
|
2,578
|
2,244
|
2,096
|
1,898
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.925
x
|
1.963
x
|
2.272
x
|
5.169
x
|
5.768
x
|
4.045
x
|
3.424
x
|
2.751
x
|
Free Cash Flow
1 |
184
|
495
|
165
|
-243
|
438
|
551
|
285
|
339
|
ROE (net income / shareholders' equity)
|
46.5%
|
54.3%
|
59.7%
|
39.6%
|
-
|
-
|
-
|
330%
|
ROA (Net income/ Total Assets)
|
8.28%
|
12.1%
|
12.5%
|
-9.62%
|
0.88%
|
5.17%
|
6.97%
|
9.12%
|
Assets
1 |
5,565
|
3,205
|
4,090
|
4,548
|
-43,036
|
3,453
|
3,291
|
3,138
|
Book Value Per Share
2 |
54.40
|
12.50
|
18.20
|
2.660
|
-4.770
|
-3.260
|
0.1800
|
3.620
|
Cash Flow per Share
|
4.030
|
9.810
|
4.750
|
-
|
9.480
|
-
|
-
|
-
|
Capex
1 |
42.4
|
62.7
|
107
|
114
|
92.8
|
78.5
|
89.1
|
101
|
Capex / Sales
|
1.34%
|
1.52%
|
2.17%
|
2.89%
|
2.61%
|
2.17%
|
2.41%
|
2.65%
|
Announcement Date
|
11/6/19
|
11/4/20
|
11/3/21
|
11/2/22
|
11/1/23
|
-
|
-
|
-
|
Last Close Price
67.75
USD Average target price
79.14
USD Spread / Average Target +16.82% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.50% | 3.84B | | +15.31% | 38.38B | | -.--% | 11.15B | | -5.30% | 7.3B | | +6.68% | 6.87B | | -3.91% | 5.91B | | -10.60% | 5.6B | | -4.54% | 5.54B | | +33.14% | 5.19B | | -13.69% | 4.58B |
Other Agricultural Chemicals
|